The purpose of this study was to document the incidence of feline tumors in the Japanese cat population. 1,078 feline tumors obtained from 1,070 cats. All of these were cytologically or histologically diagnosed at Azabu Uni- 
Introduction
Cancer is a major cause of companion animal death［2,4］ . This statement is supported by a study that determined the cause of death in a series of more than 2,000 necropsy cases［13］ . Of more than 74 million household dogs and 90 million cats in the United States, at least 4 million dogs and 4 million cats may develop cancer each year ［8］ . In the Japanese dog population, 40.1% of dogs that lived to 8 years or older were affected with tumors［12］ .
Epidemiological research for spontaneous cancers in animals contributes to not only veterinary medicine but also comparative oncology for human and companion animals. Until 1950's, very little was known about the site, type, distribution, frequency of malignant types, and biological behavior of feline tumors［3］ . This unfortunate lack of information had been improved in 1970's by reports of feline tumors from the United Kingdom and the United States［1,5,6,7,10,11］ . It is now apparent that tumors occur quite frequently in cats and that there are many differences between canine and feline tumors［7］ . On the other hand, in Japan, epidemiological studies concerning feline tumors are extremely few［14］ .
The purpose of this study, therefore, is to document age, sex, breed, type of tumors, site-specific tumor incidence, and frequency of malignant types in tumor-bearing cats, and to make comparison with dogs.
A Retrospective Study in 1,070 Feline Tumor Cases of Japan. 
Results
The population studied 
Analysis of tumor-bearing cats
The 1 In addition, all the neoplasms in the lymphoid/hematopoietic system and mast cell tumors were classified as malignant.
The lymphoid/hematopoietic system neoplasms included 39 cases of myeloproliferative diseases and 137 cases of lymphomas. The lymphomas were further classified into alimentary（32；23.4%） , anterior mediastinal（29；21.2%） , extranodal （28；20.4%, nasal lymphoma included） , cutaneous（21；15.3%） , multicentric（13；9.5%） , renal（11；8.0%）and others.
Mast cell tumors classified as an individual category in the WHO classification, included cutaneous（71；88.8%） , splenic （8；10.0%）and retroperitoneal（1；1.2%）types.
As compared to the entire tumor-bearing population, the mean age of cats with lymphoid/hematopoietic system tumors was significantly lower（8.4±4.0 years old vs 9.9±3.8 years old, p<0.001） . On the other hand, mean ages of cats with tumors in female genital system, mammary grand, head and neck, 11.0±1.0（p<0.001） , 11.3±3.3（p<0.001） , 11.2±3.9 （p=0.007） , respectively, were significantly higher than that of the entire tumor-bearing population. There was no significant difference in sex distribution between the baseline hospital population and tumor-bearing cats when the cases with mammary grand and female genital system tumors were excluded. Since all the cases with mammary grand and genital system tumors were female, with no case in the male genital system, there was a strong sex predilection with tumors in these systems.
With reference to the breed distribution of the baseline hospital population, American Shorthair cats had a significantly high incidence of respiratory tumors with an odds ratio of 3.05（p=0.043） . Persian and Siamese had significantly high incidences of mammary grand tumor with odds ratios of 2.66 and 2.80（p=0.004 and p=0.031） , respectively.
Discussion
In this study, the incidence rate of feline tumors（1,070/6,748, 15.9%）was extremely high as compared to the data reported by Uchino, et al. in which a Japanese cat population in local primary care hospitals were studied（147/5,274, 2.8%） ［14］ . A possible explanation for this difference is that the present study included a unique population of the cats with more serious diseases referred to this university hospital.
The average age was significantly higher in the tumor-bearing group than in the baseline hospital population. The average age of cats with lymphoid/hematopoietic tumors, however, was significantly younger, with a general agreement with the previous studies conducted in the United States［1,3］ .
As to the sex predilection, the incidence of tumors was significantly higher in female cats, with a male-to-female ratio of 1：1.42. According to the canine tumor studies conducted by Priester and colleagues［10］and Shida and colleagues ［12］ , the incidence of female mammary gland tumors were relatively high, and mammary gland tumors accounted for 17.0% of the total tumors in this study. Therefore, it is considered that a high incidence of the female mammary tumors in cats produced this significant gender difference. It has been reported that lymphoid/hematopoietic tumors are more common in male cats［5］ . In the present study, however, no significant sex predilection was observed with lymphoid/he- Newkirk and colleagues［9］reported six cases of UV-induced hemangiosarcomas（14%）among 43 eyelid skin and subcutaneous tumors in the cat. In the present study, of the 318 skin and subcutaneous tumors, there were only 3 hemangiosarcomas（0.9%） , and this was markedly lower when compared to the U. S. study results. This might have been due to breed differences, but there might have been differences in UV exposure between the U. S. and Japan.
Besides skin mast cell and lymphoid/hematopoietic tumors, the incidence rate of malignancies was significantly higher for the following sites in cats；urinary system, respiratory tract system, mammary gland, alimentary system, and head and neck region mostly consisted of oral tumors. In comparison with canine tumors［12］ , the odds ratio for malignancy was significantly higher for the head and neck region（5.18 fold） , mammary gland（4.55 fold） , female genitalia（3.64 fold） , and skin/subcutis（1.64 fold） . The odds ratio for malignancy was significantly lower for bones and joints（0.16 fold） .
The above results may be useful and helpful for client information, the early diagnosis and treatment of feline tumors, and also contribute the comparative oncology for human and companion animals.
